As the number of states increase where medical and recreational cannabis use is legal, so does the importance that physicians discuss with patients the effects of cannabis on those with asthma. A new survey in Annals of Allergy, ...
Feb 2, 2021
0
2
Access to legal cannabis stores is associated with a reduction in opioid related deaths in the United States, particularly those linked to synthetic opioids such as fentanyl, finds a study published by The BMJ today.
Jan 27, 2021
0
1
With medicinal cannabis now legalized in many parts of the world, there is growing interest in its use to alleviate symptoms of many illnesses including Parkinson's disease (PD). According to results of a survey of PD patients ...
Jan 26, 2021
0
23
While efforts to legalize recreational cannabis nationally have stalled in the United States, New Zealand, Mexico and Israel, Canada's legal market continues to evolve.
Jan 18, 2021
0
8
Human ReproductionWomen who use marijuana could have a more difficult time conceiving a child than women who do not use marijuana, suggests a study by researchers at the National Institutes of Health. Marijuana use among ...
Jan 11, 2021
0
10
More than half of people who use medical marijuana products to ease pain also experience clusters of multiple withdrawal symptoms when they're between uses, a new study finds.
Jan 8, 2021
2
182
In a new study, researchers at The University of New Mexico measured the effectiveness of commercially available Cannabis flower, or "buds," for alleviating feelings of stress and anxiety. Using data collected by the Releaf ...
Dec 24, 2020
1
19
Female rats that inhaled vaporized cannabis daily for a month developed a blunted physiological response to stress, according to a new study by Washington State University researchers.
Dec 22, 2020
0
115
New research suggests that cannabis use by people in care for opioid addiction might improve their treatment outcomes and reduce their risk of being exposed to fentanyl in the contaminated unregulated drug supply.
Dec 21, 2020
0
28
Medicinal cannabis could offer patients significant relief from intractable epilepsy, but cost and access barriers remain, a review has found.
Dec 18, 2020
0
0
